Jiangsu Nhwa Pharmaceutical Co., Ltd. (002262.SZ)
002262.SZ Stock Price Chart
Explore Jiangsu Nhwa Pharmaceutical Co., Ltd. interactive price chart. Choose custom timeframes to analyze 002262.SZ price movements and trends.
002262.SZ Company Profile
Discover essential business fundamentals and corporate details for Jiangsu Nhwa Pharmaceutical Co., Ltd. (002262.SZ) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
15 Jul 2008
Employees
5.92K
Website
https://www.nhwa-group.comCEO
Jiaquan Sun
Description
Jiangsu Nhwa Pharmaceutical Co., LTD produces and sells central nervous system drugs, and cardiovascular and cerebrovascular drugs in China and internationally. The company offers drugs in the anesthesia, psychiatry, and neurological categories. It also provides APIs in the areas of central nervous system, anesthetic and sedative, and others. The company was founded in 1978 and is headquartered in Xuzhou, China.
002262.SZ Financial Timeline
Browse a chronological timeline of Jiangsu Nhwa Pharmaceutical Co., Ltd. corporate events including earnings releases, dividend announcements, and stock splits.
Dividend declared on 14 May 2025
A dividend of ¥0.36 per share was announced, adjusted to ¥0.36. The dividend was paid on 14 May 2025.
Earnings released on 18 Apr 2025
EPS came in at ¥0.30 falling short of the estimated ¥0.31 by -3.23%, while revenue for the quarter reached ¥1.51B, missing expectations by 0.00%.
Earnings released on 28 Mar 2025
EPS came in at ¥0.12 falling short of the estimated ¥0.17 by -29.41%, while revenue for the quarter reached ¥1.55B, missing expectations by -6.05%.
Earnings released on 25 Oct 2024
EPS came in at ¥0.39 falling short of the estimated ¥0.41 by -4.88%, while revenue for the quarter reached ¥1.38B, missing expectations by -5.21%.
Earnings released on 30 Jul 2024
EPS came in at ¥0.36 matching the estimated ¥0.36, while revenue for the quarter reached ¥1.39B, missing expectations by -0.11%.
Dividend declared on 15 May 2024
A dividend of ¥0.32 per share was announced, adjusted to ¥0.32. The dividend was paid on 15 May 2024.
Earnings released on 19 Apr 2024
EPS came in at ¥0.26 falling short of the estimated ¥0.29 by -10.34%, while revenue for the quarter reached ¥1.34B, beating expectations by +0.52%.
Earnings released on 29 Mar 2024
EPS came in at ¥0.15 falling short of the estimated ¥0.21 by -28.57%, while revenue for the quarter reached ¥1.37B.
Earnings released on 25 Oct 2023
EPS came in at ¥0.34 surpassing the estimated ¥0.32 by +6.25%, while revenue for the quarter reached ¥1.26B, beating expectations by +0.40%.
Earnings released on 30 Jul 2023
EPS came in at ¥0.32 falling short of the estimated ¥0.36 by -11.11%, while revenue for the quarter reached ¥1.22B, beating expectations by +0.27%.
Dividend declared on 28 Apr 2023
A dividend of ¥0.20 per share was announced, adjusted to ¥0.20. The dividend was paid on 28 Apr 2023.
Earnings released on 13 Apr 2023
EPS came in at ¥0.23 surpassing the estimated ¥0.22 by +4.55%, while revenue for the quarter reached ¥1.18B, beating expectations by +5.94%.
Earnings released on 27 Feb 2023
EPS came in at ¥0.15 matching the estimated ¥0.15, while revenue for the quarter reached ¥1.18B, beating expectations by +0.14%.
Earnings released on 26 Oct 2022
EPS came in at ¥0.29 matching the estimated ¥0.29, while revenue for the quarter reached ¥1.12B, missing expectations by 0.00%.
Earnings released on 29 Jul 2022
EPS came in at ¥0.26 surpassing the estimated ¥0.24 by +8.33%, while revenue for the quarter reached ¥1.01B, missing expectations by -38.96%.
Dividend declared on 13 May 2022
A dividend of ¥0.20 per share was announced, adjusted to ¥0.20. The dividend was paid on 13 May 2022.
Earnings released on 22 Apr 2022
EPS came in at ¥0.19 surpassing the estimated ¥0.15 by +26.67%, while revenue for the quarter reached ¥992.59M, beating expectations by +30.03%.
Earnings released on 25 Feb 2022
EPS came in at ¥0.12 falling short of the estimated ¥0.17 by -29.41%, while revenue for the quarter reached ¥1.04B, beating expectations by +9.06%.
Earnings released on 25 Oct 2021
EPS came in at ¥0.26 falling short of the estimated ¥0.30 by -13.33%, while revenue for the quarter reached ¥1.03B.
Earnings released on 30 Jul 2021
EPS came in at ¥0.24, while revenue for the quarter reached ¥960.95M.
Dividend declared on 2 Jun 2021
A dividend of ¥0.10 per share was announced, adjusted to ¥0.10. The dividend was paid on 2 Jun 2021.
Earnings released on 29 Apr 2021
EPS came in at ¥0.17, while revenue for the quarter reached ¥904.07M.
Earnings released on 26 Feb 2021
EPS came in at ¥0.15, while revenue for the quarter reached ¥986.79M.
Earnings released on 25 Oct 2020
EPS came in at ¥0.21 surpassing the estimated ¥0.19 by +10.53%, while revenue for the quarter reached ¥892.11M.
Earnings released on 31 Jul 2020
EPS came in at ¥0.21 falling short of the estimated ¥0.39 by -46.15%, while revenue for the quarter reached ¥744.88M.
002262.SZ Stock Performance
Access detailed 002262.SZ performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.